Skip to content

Inventory Stepup at other companies

Cronos Group logo
Cronos GroupCRON
$0-100%
Loar Holdings logo
Loar HoldingsLOAR
$4.92M+43,598%
Distribution Solutions Group, Inc. logo
Distribution Solutions Group, Inc.DSGR
$24K
Boston Scientific logo
Boston ScientificBSX
$2M-97.5%
Innoviva, Inc. logo
Innoviva, Inc.INVA
$1.15M+371%
Bausch + Lomb logo
Bausch + LombBLCO
$0-100%

Segments

By product

See full
Hemangeol$1.13M

Other financials

Income statement

See full
Revenue$24.3M+40.4%
Gross profit$14.7M+49.4%
Operating income$2.4M+614%
Net income$1.6M+199%
EPS (diluted)$0.05+183%

Balance sheet

See full
Cash & equivalents$19.7M+12.9%
Total debt$31.3M+3.7%
Total equity$30.6M+25.2%
Total assets$97.7M+16.3%

Cash flow

See full
Operating cash flow$7.4M+254%
CapEx$75.0K
Free cash flow$7.3M+251%

Valuation

See full
Market cap$930.79M+162%
Enterprise value$942.39M+156%
P/S10.7×+3.4×

Profitability

See full
Gross margin54.8%-3.7pp
Operating margin-15.1%
Net margin-9.5%-2.7pp
FCF margin17.1%

Returns & leverage

See full
Return on equity-34.2%+0.9pp
Debt / equity-0.2×
Current ratio1.2×-0.8×

Where this comes from

Reported directly by Eton Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept eton:InventoryStepup.

The official record: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eton Pharmaceuticals, Inc.'s inventory stepup.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Eton Pharmaceuticals, Inc.'s inventory stepup?
Eton Pharmaceuticals, Inc. (ETON) reported inventory stepup of $350K in Q1 2026.
How has Eton Pharmaceuticals, Inc.'s inventory stepup changed year-over-year?
Eton Pharmaceuticals, Inc.'s inventory stepup decreased by 69.4% year-over-year, from $1.14M to $350K.
What does inventory stepup mean?
Represents the non-cash adjustment to inventory value resulting from purchase price accounting in a business combination. This step-up reflects the fair value adjustment of acquired inventory above its historical cost basis, which is subsequently expensed as the inventory is sold. It is a critical metric for understanding the impact of acquisition accounting on reported cost of goods sold and gross margins.